DOI:
10.1055/s-00000021
Gesundheitsökonomie & Qualitätsmanagement
LinksClose Window
References
Taylor RS, Drummond MF, Salkeld G et al.
Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle.
British Medical Journal 2004;
329 (7472) 972-975
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.